Respiratory infections, particularly viral ones, are the single most common trigger of COPD exacerbations, but they are far from the only cause. Air pollution, cold weather, poor inhaler technique, acid reflux, and even high blood sugar can each independently set off a flare-up or make one worse. What makes exacerbations tricky is that multiple triggers often pile on at once, and some people with COPD are biologically prone to flaring up more than others regardless of what sets it off.
How Exacerbations Are Defined
A COPD exacerbation is formally defined as an acute worsening of respiratory symptoms that leads to additional treatment beyond what a person normally uses. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) classifies them by severity: mild if only a rescue inhaler is needed, moderate if antibiotics or oral steroids are added, and severe if the person ends up in an emergency room or hospital.1European Respiratory Journal. What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement In practice, that means a flare-up can range from a few rough days at home to a life-threatening event requiring ventilatory support. The common thread is a noticeable step-change from the person’s usual baseline of cough, breathlessness, and sputum production.
Viral Infections Are the Leading Trigger
Over the past two decades, research has consistently shown that viral infection is the most common cause of exacerbation in people with chronic airways disease.2PubMed Central. Rhinovirus-Induced Exacerbations of Asthma and COPD Respiratory viruses are found in roughly 30 to 50 percent of infectious COPD exacerbations, and rhinovirus, the same family of viruses behind the common cold, is the pathogen isolated most often.3PubMed Central. Rhinovirus and COPD airway epithelium Influenza, respiratory syncytial virus (RSV), and coronaviruses also contribute, but rhinovirus dominates the statistics.
The connection between rhinovirus and flare-ups is not just correlational. A pilot study experimentally infected people with mild to moderate COPD with rhinovirus and confirmed that the virus alone was sufficient to trigger an exacerbation, offering direct proof that a simple cold virus can destabilize COPD-damaged airways.4International Journal of Chronic Obstructive Pulmonary Disease. Pathophysiology of viral-induced exacerbations of COPD This helps explain why flare-ups spike during cold and flu season: more circulating viruses means more chances for a person with COPD to catch one.
Bacteria and What Happens When They Shift
Bacteria play a complicated role. In one study of severe exacerbations requiring hospitalization, viral or bacterial infection was detected in about 78 percent of cases. Bacteria were found in roughly 55 percent of exacerbations, viruses in about 48 percent, and co-infection with both occurred in a quarter of patients. People with co-infection had worse lung function and longer hospital stays than those with only one type of pathogen or no detected infection at all.5American Journal of Respiratory and Critical Care Medicine. Infections and Airway Inflammation in Chronic Obstructive Pulmonary Disease Severe Exacerbations
The picture gets more interesting when you look at the broader microbial community rather than just a few known pathogens. Research tracking the airway microbiome before, during, and after exacerbations found that flare-ups were accompanied by a surge in Proteobacteria, a broad group that includes many inflammatory organisms, some of which are not the “usual suspect” COPD pathogens at all. At the same time, microbial functions related to producing anti-inflammatory and antimicrobial compounds declined, while functions linked to triggering inflammation ramped up.6PubMed Central. Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease In other words, the microbial ecosystem in the airways tilts toward a more hostile configuration during a flare-up, and that shift itself may fuel the inflammation.
When Pseudomonas Takes Hold
Among bacteria, Pseudomonas aeruginosa deserves special mention. This organism tends to show up in people with more advanced COPD, and once it colonizes the airways, it is extremely hard to get rid of. Picking up a new strain of Pseudomonas has been directly associated with triggering an exacerbation.7American Journal of Respiratory and Critical Care Medicine. Pseudomonas aeruginosa in Chronic Obstructive Pulmonary Disease In a prospective study of patients with frequent hospitalized exacerbations, Pseudomonas persisted in sputum despite appropriate antibiotic treatment, and its presence was linked to three or more hospital readmissions over a year.8PubMed. Pseudomonas aeruginosa in Chronic Obstructive Pulmonary Disease Patients with Frequent Hospitalized Exacerbations
More recent data put a number on the risk: people colonized with Pseudomonas had roughly triple the odds of a moderate-to-severe exacerbation and about four times the odds of developing pneumonia compared with those who were not colonized.9PubMed Central. Clinical Implications of Pseudomonas Aeruginosa Colonization in Chronic Obstructive Pulmonary Disease Patients If you or someone you know with COPD keeps getting sputum cultures that grow Pseudomonas, that colonization status itself is a strong predictor of future trouble.
Air Pollution and Cold Weather
Environmental exposures are major, and often underappreciated, triggers. A meta-analysis of 18 studies found that for every 10 μg/m³ increase in daily particulate matter (PM10), COPD hospitalizations rose by about 2.7 percent. Nitrogen dioxide, ozone, sulfur dioxide, and carbon monoxide have all been independently linked to more emergency department visits and hospital admissions for COPD.10PubMed Central. The Effects of Air Pollution and Temperature on COPD A decade-long case-crossover study confirmed these associations and added that lower temperatures in the period surrounding hospital admission were tied not just to more exacerbations but to a higher probability of dying in the hospital.11PLOS ONE. Analysis of environmental risk factors for chronic obstructive pulmonary disease exacerbation: A case-crossover study (2004-2013)
The seasonal pattern of exacerbations, which peaks in winter, is well documented. This winter spike is thought to result from several overlapping factors: more viral infections circulating in cold, damp conditions, less physical activity, more time in enclosed spaces with poor ventilation, and the direct irritant effect of cold air on already-inflamed airways. The magnitude of this seasonal swing varies with latitude and is more pronounced in temperate climates, where people may have less protection from both indoor and outdoor cold exposure.12PubMed Central. The causes and consequences of seasonal variation in COPD exacerbations
Acid Reflux as a Hidden Driver
Gastroesophageal reflux disease (GERD) is surprisingly common in COPD and functions as a trigger that many people do not connect to their lungs. Reflux that reaches high enough in the esophagus can lead to tiny amounts of stomach contents being aspirated into the airways, provoking inflammation and bronchospasm. GERD has been identified as a significant independent predictor of acute exacerbations.13PubMed Central. Gastroesophageal reflux disease in COPD: links and risks Research using pH monitoring has shown that the higher the reflux reaches in a person’s esophagus, the more COPD exacerbations they experience per year.14PubMed. Does gastroesophageal reflux increase chronic obstructive pulmonary disease exacerbations?
This relationship creates a vicious cycle. COPD itself, with its hyperinflation of the lungs and the flattening of the diaphragm, can worsen reflux by increasing pressure on the stomach. Systemic steroids used to treat flare-ups can also relax the lower esophageal sphincter, potentially feeding more reflux. For people with COPD who have frequent unexplained flare-ups, untreated GERD is worth investigating.
Inhaler Misuse and Non-Adherence
You can have the best maintenance medications on the shelf and still flare up if you are not using them correctly or consistently. Decreased adherence to COPD inhalers is associated with increased risk of exacerbations and higher long-term mortality.15PubMed Central. Inhaler Adherence in COPD: A Crucial Step Towards the Correct Treatment Adherence in COPD tends to be worse than in many other chronic diseases, partly because inhaler devices can be genuinely confusing. Different devices require different inhalation speeds, coordination of hand and breath, and priming steps.
A systematic review examining the real-world effects of inhaler errors found that even among patients who were using their inhalers regularly, those who made critical technique errors had a trend toward more moderate exacerbations than those who inhaled correctly, though the difference in one key study was not large enough to reach statistical significance.16BMJ Open. Systematic review of the effects of patient errors using inhaled delivery systems on clinical outcomes in COPD The broader point stands: using your inhaler every day but doing it wrong may not protect you the way it should. Getting an annual inhaler technique check from a pharmacist or respiratory therapist is one of the simplest ways to reduce exacerbation risk.
Psychological Stress and Perceived Triggers
Patients themselves report psychological stress as a recognizable trigger of their flare-ups, and this is not just subjective impression. A validated questionnaire study identified five distinct categories of perceived exacerbation triggers: weather and climate, air pollution and irritants, exercise, infection or illness, and psychological factors. All five correlated with functional status, exacerbation frequency, and healthcare use.17PubMed. Towards an assessment of perceived COPD exacerbation triggers: Initial development and validation of a questionnaire The mechanism likely involves stress-related changes in breathing pattern, increased muscle tension, and possibly cortisol-driven immune suppression, though this area is not as well studied as infections or pollution. The practical takeaway is that anxiety and depression, both of which are common in COPD, are not just consequences of the disease; they may actively contribute to its flare-ups.
What Happens Inside the Lungs During a Flare-Up
Whatever the trigger, the downstream chain of events inside the airways follows a broadly similar pattern. Inflammatory cells flood in. During exacerbations, sputum neutrophils spike dramatically, and the severity of the neutrophil surge tracks with how bad the flare-up is, independent of whether a virus or bacterium is involved. Virus-associated exacerbations also bring a rise in eosinophils, while levels of inflammatory signaling molecules like IL-8 and RANTES climb as well.18European Respiratory Journal. Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease
This inflammation causes the airway walls to swell and produce more mucus, narrowing the already-obstructed airways further. That narrowing creates a mechanical problem: air gets trapped behind the inflamed, mucus-clogged airways. The lungs hyperinflate, meaning they cannot fully deflate between breaths. This dynamic hyperinflation, along with critical expiratory flow limitation, is what drives the sensation of severe breathlessness during a flare-up.19Thorax. COPD exacerbations · 3: Pathophysiology Studies measuring inspiratory capacity at admission for a severe exacerbation found it significantly reduced, recovering only as the flare-up resolved.20PubMed Central. Static and dynamic hyperinflation during severe acute exacerbations of chronic obstructive pulmonary disease This trapped-air effect is why flare-ups feel so different from the usual day-to-day breathlessness: the lungs are physically over-expanded, and the diaphragm is working at a mechanical disadvantage.
The Cardiovascular Danger After a Flare-Up
Exacerbations do not just damage the lungs. They destabilize the cardiovascular system. In the 91 days following a severe exacerbation, the risk of heart attack is roughly 2.5 times higher than baseline, and the risk of ischemic stroke nearly doubles. Even moderate exacerbations carry elevated risk, with heart attack odds about 1.6 times higher and stroke odds about 1.5 times higher.21PubMed Central. Myocardial Infarction and Ischemic Stroke after Exacerbations of Chronic Obstructive Pulmonary Disease The mechanisms include systemic inflammation spilling over from the lungs, hypoxia stressing the heart, and increased blood viscosity and clotting tendency.
This cardiovascular link has an important diagnostic implication. Pulmonary embolism, a blood clot in the lung arteries, can mimic or co-occur with a COPD exacerbation. It is estimated that about one in four patients presenting with an “unexplained” exacerbation, one without an obvious infectious cause, may actually have a pulmonary embolism.22PubMed Central. COPD and PE: a clinical dilemma Pleuritic chest pain and signs of heart failure are clues, but since many COPD patients already have baseline breathlessness and chest tightness, the overlap can make diagnosis genuinely difficult.23PubMed. Prevalence and Localization of Pulmonary Embolism in Unexplained Acute Exacerbations of COPD If a flare-up does not improve with standard treatment or has no clear infectious trigger, pulmonary embolism should be on the radar.
The Frequent Exacerbator
Some people with COPD flare up repeatedly while others with apparently similar lung function do not. Researchers call this the “frequent exacerbator” phenotype, and it appears to be a relatively stable trait: if you had frequent exacerbations last year, you are likely to have them this year too. Compared with infrequent exacerbators, these patients tend to be older, have more emphysema visible on CT scans, worse lung function across multiple measures, and report more symptoms on standardized questionnaires.24PubMed Central. Chronic Obstructive Pulmonary Disease with Frequent Exacerbator Phenotype: What is Different in these Patients?
Blood markers tell part of the story. Frequent exacerbators have higher neutrophil-to-lymphocyte ratios and other inflammatory indices, suggesting a more chronically inflamed state even between flare-ups.25PubMed Central. Biomarkers (NLR, PLR, SII) for Frequent COPD Exacerbations: Diagnostic and Clinical Management Implications in a Retrospective Study A predictive model incorporating age, sex, hospital stay length, several blood cell counts, and metabolic markers managed moderate accuracy in identifying who would be a frequent exacerbator, though the prediction is far from perfect.26PubMed Central. A predictive model for frequent exacerbator phenotype of acute exacerbations of chronic obstructive pulmonary disease The honest reality is that we can identify many of the risk factors for being a frequent exacerbator but cannot yet precisely predict who will be one.
Blood Sugar and Metabolic Factors
A less intuitive risk factor is elevated blood glucose. People with COPD and poorly controlled blood sugar face a substantially higher risk of severe exacerbation. One study found that those with high HbA1c levels (a measure of average blood sugar over the preceding months) had roughly 2.7 times the risk of a severe exacerbation compared with those whose blood sugar was well controlled, even after accounting for age, smoking status, disease severity, steroid use, and cardiovascular disease.27PubMed Central. Elevated Blood Glucose is Associated with Severe Exacerbation of Chronic Obstructive Pulmonary Disease The relationship is complicated by the fact that oral steroids, a mainstay of exacerbation treatment, themselves raise blood sugar, creating yet another feedback loop. For people with both COPD and diabetes, keeping glucose in reasonable range appears to be a meaningful lever for reducing flare-up risk.
Fungal Sensitization
Allergic sensitization to environmental fungi is an emerging area of COPD research. People with COPD who have immune sensitivity to common fungal species like Aspergillus experience more frequent exacerbations, more symptoms, and worse lung function. Researchers using clustering analysis have identified a “highly sensitized fungal predominant” subgroup that stands out for its poor clinical outcomes.28PubMed Central. Environmental fungal sensitisation associates with poorer clinical outcomes in COPD This matters because fungal sensitization is testable with straightforward blood or skin-prick tests, and in some cases treatment with antifungal medication or targeted management of the allergic component may reduce exacerbation frequency. It is an underrecognized trigger, particularly in people whose flare-ups are accompanied by eosinophilic inflammation rather than purely neutrophilic.
Why Symptoms Worsen at Night
Many people with COPD notice that their breathing is worst at night and first thing in the morning, and this pattern plays into exacerbation timing. The explanation involves the body’s circadian rhythm and its influence on the vagus nerve, which controls airway tone. During deep sleep phases, vagal activity increases, boosting mucus secretion, blood flow to the bronchial walls (which worsens inflammation), and the baseline constriction of the airways.29International Journal of Chronic Obstructive Pulmonary Disease. Day and Night Control of COPD and Role of Pharmacotherapy: A Review In someone with healthy airways, these changes are trivial. In someone whose airways are already inflamed and narrowed, they can tip the balance from manageable symptoms to crisis. This circadian vulnerability also means that a viral infection or pollution exposure that has been quietly building inflammation during the day may manifest as a full-blown exacerbation overnight or at dawn.
Long-Term Antibiotics to Prevent Flare-Ups
Given how central infection is to exacerbation risk, researchers have tested whether low-dose, long-term antibiotic therapy can reduce flare-up frequency. The most studied approach involves taking the macrolide antibiotic azithromycin daily. In a landmark trial, people taking azithromycin went roughly 266 days before their first exacerbation compared with 174 days for those on placebo, and the overall exacerbation rate was about 27 percent lower in the azithromycin group.30PubMed Central. Azithromycin for prevention of exacerbations of COPD A systematic review and meta-analysis combining multiple trials confirmed these benefits, finding that long-term macrolide use cut the odds of having one or more exacerbations by about 60 percent and reduced the yearly exacerbation rate by about 40 percent, with a minimum of six months needed for the effect to materialize.31PubMed Central. Long-term macrolide treatment for the prevention of acute exacerbations in COPD: a systematic review and meta-analysis
The trade-offs are real, though. Macrolides carry a risk of hearing loss, cardiac rhythm disturbances, and antibiotic resistance. Azithromycin prophylaxis is typically reserved for people who continue to have frequent exacerbations despite optimized inhaler therapy, and it requires ECG monitoring and periodic hearing checks. It is not a first-line approach, but for the right patient it can be a meaningful intervention.
Multiple Triggers, One Flare-Up
In practice, most exacerbations are not caused by a single neat trigger. A person catches a cold virus during a week of poor air quality, while also dealing with undertreated reflux and having skipped their maintenance inhaler a few times. Each factor alone might not have been enough, but stacked together they overwhelm the lungs’ limited reserve. Understanding the full range of triggers, not just the infectious ones, opens up more avenues for prevention. Getting a flu vaccine, staying indoors on high-pollution days, managing GERD, reviewing inhaler technique regularly, and controlling blood sugar are each modest interventions on their own. Together, they reduce the total load of insults the airways have to absorb, and that can mean the difference between a stable winter and a hospitalization.